MAPT and Alzheimer disease: The conventional diagnosing methods of AD focus on the examination of Aβ deposition, pathologic tau, and neurodegeneration through analysis of biomarkers in the CSF [36], positron emission tomography (PET) [37], and magnetic resonance imaging (MRI) [38].